Agilent Technologies, Inc.
A- Exchange
- NYSE
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001090872
In the last 90 days, Agilent Technologies, Inc. insiders filed 0 open-market purchases and 1 sale; 1,140 institutions reported holding it in 13F filings for Q2 2026, worth $34.6B in total; Greenhaven Associates is the only superinvestor holding it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 12:23 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Oct 31, 2025 | Oct 31, 2024 | Oct 31, 2023 | Oct 31, 2022 | Oct 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Nov 24, 2025 | Nov 25, 2024 | Nov 20, 2023 | Nov 21, 2022 | Nov 22, 2021 |
| Revenue | $6.95B | $6.51B | $6.83B | $6.85B | $6.32B |
| Cost of revenue | $3.31B | $2.98B | $3.37B | $3.13B | $2.91B |
| Research and development | $455.0M | $479.0M | $481.0M | $467.0M | $441.0M |
| Selling, general and administrative | $1.71B | $1.57B | $1.63B | $1.64B | $1.62B |
| Operating income | $1.48B | $1.49B | $1.35B | $1.62B | $1.35B |
| Interest expense | $112.0M | $96.0M | $95.0M | $84.0M | $81.0M |
| Income tax | $132.0M | $232.0M | $99.0M | $250.0M | $150.0M |
| Net income | $1.30B | $1.29B | $1.24B | $1.25B | $1.21B |
| EPS, basic | $4.59 | $4.44 | $4.22 | $4.19 | $3.98 |
| EPS, diluted | $4.57 | $4.43 | $4.19 | $4.18 | $3.94 |
| Weighted shares, basic | 284.0M | 290.0M | 294.0M | 299.0M | 304.0M |
| Weighted shares, diluted | 285.0M | 291.0M | 296.0M | 300.0M | 307.0M |
| Margins and growth | |||||
| Operating margin | 21.3% | 22.9% | 19.8% | 23.6% | 21.3% |
| Net margin | 18.8% | 19.8% | 18.1% | 18.3% | 19.1% |
| Revenue growth, year over year | +6.7% | −4.7% | −0.2% | +8.4% | +18.4% |
| Net income growth, year over year | +1.1% | +4.0% | −1.1% | +3.6% | +68.3% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025! | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Oct 31, 2025 | Oct 31, 2024 | Oct 31, 2023 | Oct 31, 2022 | Oct 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Nov 24, 2025 | Nov 25, 2024 | Nov 20, 2023 | Nov 21, 2022 | Nov 22, 2021 |
| Cash and equivalents | $1.79B | $1.33B | $1.59B | $1.05B | $1.48B |
| Accounts receivable | $1.49B | $1.32B | $1.29B | $1.41B | $1.17B |
| Inventory | $1.02B | $972.0M | $1.03B | $1.04B | $830.0M |
| Total current assets | $4.59B | $3.96B | $4.19B | $3.78B | $3.80B |
| Property, plant and equipment | $2.02B | $1.78B | $1.27B | $1.10B | $945.0M |
| Goodwill | $4.47B | $4.48B | $3.96B | $3.95B | $3.98B |
| Intangible assets | $445.0M | $547.0M | $475.0M | $821.0M | $981.0M |
| Total assets | $12.7B | $11.8B | $10.8B | $10.5B | $10.7B |
| Accounts payable | $570.0M | $540.0M | $418.0M | $580.0M | $446.0M |
| Short-term debt | $304.0M | $45.0M | $0 | $36.0M | $0 |
| Total current liabilities | $2.35B | $1.90B | $1.60B | $1.86B | $1.71B |
| Long-term debt | $3.05B | $3.35B | $2.73B | $2.73B | $2.73B |
| Total liabilities | $5.99B | $5.95B | $4.92B | $5.23B | $5.32B |
| Shareholders' equity | -$226.0M | $5.90B | $5.84B | $5.30B | $5.39B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Oct 31, 2025 | Oct 31, 2024 | Oct 31, 2023 | Oct 31, 2022 | Oct 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Nov 24, 2025 | Nov 25, 2024 | Nov 20, 2023 | Nov 21, 2022 | Nov 22, 2021 |
| Operating cash flow | $1.56B | $1.75B | $1.77B | $1.31B | $1.49B |
| Capital expenditures | $407.0M | $378.0M | $298.0M | $291.0M | $188.0M |
| Free cash flow | $1.15B | $1.37B | $1.47B | $1.02B | $1.30B |
| Depreciation and amortization | $288.0M | $257.0M | $271.0M | $317.0M | $321.0M |
| Stock-based compensation | $128.0M | $129.0M | $111.0M | $125.0M | $110.0M |
| Dividends paid | $282.0M | $274.0M | $265.0M | $250.0M | $236.0M |
| Share buybacks | $425.0M | $1.15B | $575.0M | $1.14B | $788.0M |
| Investing cash flow | -$394.0M | -$1.26B | -$310.0M | -$338.0M | -$749.0M |
| Financing cash flow | -$715.0M | -$752.0M | -$930.0M | -$1.37B | -$696.0M |
| Net change in cash | $459.0M | -$261.0M | $537.0M | -$434.0M | $43.0M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 1.8% | 2.0% | 1.6% | 1.8% | 1.7% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Aug 26, 2026 | 281.9M | −0.6% | SEC |
| May 27, 2026 | 282.4M | −0.6% | SEC |
| Feb 25, 2026 | 282.6M | −0.9% | SEC |
| Dec 10, 2025 | 283.5M | −0.7% | SEC |
| Aug 21, 2025 | 283.5M | −1.3% | SEC |
| May 23, 2025 | 284.1M | −2.6% | SEC |
| Feb 26, 2025 | 285.1M | −2.7% | SEC |
| Dec 9, 2024 | 285.6M | −2.5% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
- A column marked ! failed an accounting identity (gross profit = revenue − cost of revenue, or assets = liabilities + equity, within 1%). Its numbers are shown as filed.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.